Industry Canada might have a little bit more of a handle on that, but based on my knowledge of the industry a little bit, I can say that we're always fighting for mandates from pharmaceutical companies that usually operate in many different countries. We sometimes hold our own, but I think there's more work to be done.
The general statistic on research and development as a percentage of sales in Canada is 8.5% investments, as a percentage of sales, for Rx and D members, and for all patentees it's 8.3%. That's pretty competitive. I think there are probably a few countries that might be a bit higher than that, but that sort of keeps us in the ballpark in terms of new patents and the research that goes along with that.